Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|December 14, 2017

Additional Size for Quaternary Diaphragm Pumps

The Quattroflow QF10k size pump from PSG, a Dover company, has been added to its line of quaternary, four-piston diaphragm pumps.

PSG, a Dover company, has expanded its Quattroflow line of quaternary, four-piston diaphragm pumps to include the QF10k size pump. The pump has been designed to fill the gap between the existing QF4400/5050 and QF20k pump sizes and provides a maximum flow rate of 10,000 lph.

Product features include a stainless-steel pump chamber design, a maximum pressure of 6 bar (87 psi), 20:1 turn-down ratio, linear flow performance, and high-flow stability even at low flow rates. Additionally, the pump offers clean-in-place/steaming-in-place and autoclave capabilities. Available accessories include control box, power box, diaphragm sensor, and proportional–integral–derivative controller. Typical applications include chromatography and cross-flow filter systems.


Related to this article

The BioPharm Brief: Cosentyx Approved in Polymyalgia Rheumatica, a Phase 3 Survival Win for an AML Vaccine, and $173 Million for In Vivo Bone Marrow Editing
FDA approves Novartis’ Cosentyx as the first anti-IL-17 biologic for polymyalgia rheumatica, SELLAS Life Sciences’ WT1-targeted peptide vaccine galinpepimut-S meets its overall survival primary endpoint in the phase 3 REGAL trial in AML, and Marrow Therapeutics launches with $173 million to develop bone marrow-targeted genetic medicines.